Carter A. Wright, Jared W Taylor, M. Cochran, J. Lawlor, Belle A. Moyers, M. Amaral, Zachary T Bonnstetter, Princess Carter, Veronika Solomon, R. Myers, M. N. Love, D. Geldmacher, S. Cooper, E. Roberson, J. N. Cochran
tlooto Summary
Patients with early-onset Alzheimer's had higher non-APOE PRSs than patients with late-onsets Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early -onset neurodegenerative disease risk.
Abstract
We collected and analyzed genomic sequencing data from individuals with clinician-diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with 68 newly described in this report. Of those 68, 62 patients self-reported white, non-Hispanic ethnicity and 6 reported as African–American, non-Hispanic. Fifty-three percent of patients had a returnable variant. Five patients harbored a pathogenic variant as defined by the American College of Medical Genetics criteria for pathogenicity. A polygenic risk score (PRS) was calculated for Alzheimer's patients in the total cohort and compared to the scores of a late-onset Alzheimer's cohort and a control set. Patients with early-onset Alzheimer's had higher non-APOE PRSs than patients with late-onset Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early-onset neurodegenerative disease risk.
Citation format
WRIGHT, Carter A., et al. Contributions of rare and common variation to early-onset and atypical dementia risk. Cold Spring Harbor Molecular Case Studies, 2023, 9.